PHASE 2 STUDY: RAD001 WITH AND WITHOUT BEVACIZUMAB IN SPORADIC AND NEUROFIBROMATOSIS TYPE 1-RELATED REFRACTORY MALIGNANT PERIPHERAL NERVE SHEATH TUMO

Sarc, Ann Arbor MI

Investigators